These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8298666)

  • 21. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol.
    Winkler UH; Ferguson H; Mulders JA
    Contraception; 2004 Jun; 69(6):469-76. PubMed ID: 15157791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.
    Kaunitz AM
    Contraception; 2000 May; 61(5):295-302. PubMed ID: 10906499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
    Halbe HW; de Melo NR; Bahamondes L; Petracco A; Lemgruber M; de Andrade RP; da Cunha DC; Guazelli CA; Baracat EC
    Eur J Contracept Reprod Health Care; 1998 Sep; 3(3):113-20. PubMed ID: 9853201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of the low dose oral contraceptive novynette].
    Uchikova E; Milchev N
    Akush Ginekol (Sofiia); 2003; 42(4):15-6. PubMed ID: 14577362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
    Skouby SO
    Int J Fertil; 1987; 32 Suppl():45-8. PubMed ID: 2906346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The triphasics: insights for effective clinical use.
    Youngkin EQ; Miller LG
    Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion.
    Schleussner E; Brueckner T; Brautigam J; Michels W
    Gynecol Endocrinol; 2001 Aug; 15(4):259-64. PubMed ID: 11560098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A clinical trial of a monophasic contraceptive preparation containing ethinyl estradiol and desogestrel].
    Bilotta P; Favilli S
    Akush Ginekol (Mosk); 1992; (8-12):40-3. PubMed ID: 1292360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of two monophase oral contraceptives with desogestrel].
    Uchikova E; Milchev N; Markova D; Batashki I; Gŭrova A
    Akush Ginekol (Sofiia); 2007; 46(2):18-21. PubMed ID: 17469446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended regimens of the vaginal contraceptive ring: cycle control.
    Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF
    Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol. Latin American Oral Contraceptive Study Group.
    Contraception; 1994 Sep; 50(3):201-14. PubMed ID: 7805371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 microg/ ethinylestradiol 15 microg and a 21-day regimen of desogestrel 150 microg/ethinylestradiol 20 microg.
    Eur J Contracept Reprod Health Care; 1999 Nov; 4 Suppl 2():17-25. PubMed ID: 14677621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.
    Chavez A; DelConte A
    Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):75-83. PubMed ID: 10427482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive.
    Ferguson H; Vree ML; Wilpshaar J; Eskes TK
    Eur J Contracept Reprod Health Care; 2000 Mar; 5(1):35-45. PubMed ID: 10836661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of desogestrel, gestodene, and other factors on spotting and bleeding.
    Rosenberg MJ; Waugh MS; Higgins JE
    Contraception; 1996 Feb; 53(2):85-90. PubMed ID: 8838484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of a 2-phase preparation (Oviol 22) with a low-dose 1-phase preparation (Ovoresta M)].
    Dik M; Eckert H; Hönes S; Schindler AE
    Geburtshilfe Frauenheilkd; 1984 Dec; 44(12):808-12. PubMed ID: 6570117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials.
    Darney P
    Contraception; 1993 Oct; 48(4):323-37. PubMed ID: 8222660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations.
    Bäckström T; Hansson-Malmström Y; Lindhe BA; Cavalli-Björkman B; Nordenström S
    Contraception; 1992 Sep; 46(3):253-68. PubMed ID: 1451521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contraceptive efficacy and acceptability of a monophasic oral contraceptive containing 30 microg ethinyl estradiol and 150 microg desogestrel in Latin-American women.
    Comparato MR; Yabur JA; Bajares M
    Adv Contracept; 1998 Mar; 14(1):15-26. PubMed ID: 9587005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.